Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Amgen Stock Hits Record High Amid Strong Earnings and Revenue Growth

Guavy AI Editorial Team
Instruments
AMGN
Share

Amgen's stock has reached an all-time high of $422.49 USD, and is currently trading at $424.54 USD.

This milestone marks a significant achievement for the biotechnology company, which has seen its stock price surge by 47.6% over the past year.

According to InvestingPro analysis, Amgen's stock remains undervalued with a Fair Value of $443.20 USD, suggesting further upside potential.

The surge in Amgen's stock price reflects the company's strong performance and investor confidence, as it continues to innovate and expand its portfolio in the healthcare sector.

More on Stocks

Stocks just now

UK and Google Launch Trial to Reduce Aviation's Climate Impact Through Contrail-Free Flight Paths

Stocks just now

UK, Google Test Flight Path Changes to Tackle Aviation Emissions

Stocks 1m ago

Google Teams Up with UK Government to Tackle Aviation's Contrail Problem

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy